City

Houston (1)

Portland (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Phase

phase 1 (1)

phase 2 (1)

Sponsor

M.D. Anderson Cancer Center (1)

OHSU Knight Cancer Institute (1)

Collaborator

Novartis Pharmaceuticals (1)

Oregon Health and Science University (1)

Intervention

doxorubicin hydrochloride (1)

laboratory biomarker analysis (1)

pharmacological study (1)

quality-of-life assessment (1)

ribociclib (1)

sintilimab (1)

Study Documents

Intervention Type

other (2)

biological (1)

drug (1)

Funder Type

Other (2)

Study Type

Interventional (2)

locally advanced angiosarcoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

Active, not recruiting

Advanced Soft Tissue Sarcoma
+26 more

Doxorubicin Hydrochloride
+3 more

Portland, Oregon

OHSU Knight Cancer Institute

Jan 6, 2023

Locally Advanced Angiosarcoma, Metastatic Angiosarcoma, Recurrent Angiosarcoma Trial in Houston (Quality-of-Life Assessment,

Recruiting

Locally Advanced Angiosarcoma
+2 more

Quality-of-Life Assessment
Sintilimab

Houston, Texas

M D Anderson Cancer Center

Jul 31, 2022